BioNTech SE ADR buy Gilbert
Start price
09.07.21
/
0%
€184.50
Target price
09.07.22
-
Performance (%)
-0.11%
End price
09.07.21
€184.30
Summary
This prediction ended on 09.07.21 with a price of €184.30. During the runtime of the prediction for BioNTech SE ADR the price only changed by -0.11%. This prediction was marked as speculative and is excluded from Gilbert's performance statistics.Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% | - |
iShares Core DAX® | 1.665% | 0.362% | 17.556% | 15.301% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% | 36.536% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% | 10.880% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% | 36.919% |
According to Gilbert what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
Growths faster than the competition
Could be worthwhile Investment >10% per year
Cons
High risks in the balance sheet
Comments by Gilbert for this prediction
In the thread Biontech SE diskutieren
Buy BioNTech SE ADR
In the thread Trading Biontech SE
Buy beendet
Stopped prediction by Gilbert for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€291.70
23.09.21
23.09.21
-
23.09.25
23.09.25
-67.72%
12.01.24
12.01.24
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€378.60
10.08.21
10.08.21
-
10.08.24
10.08.24
2.06%
10.08.21
10.08.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€162.50
10.05.21
10.05.21
-
10.05.26
10.05.26
1.60%
27.05.21
27.05.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€125.05
17.04.21
17.04.21
-
17.04.23
17.04.23
5.28%
06.05.21
06.05.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€99.38
08.02.21
08.02.21
-
08.02.22
08.02.22
26.58%
16.04.21
16.04.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€96.99
08.02.21
08.02.21
-
08.02.22
08.02.22
2.46%
08.02.21
08.02.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€84.76
13.01.21
13.01.21
€103.00
14.43%
08.02.21
08.02.21
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet